REEDOS 50 lamotrigine 50 mg dispersible/chewable tablets bottle

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

lamotrigine, Quantity: 50 mg

Prieinama:

Strides Pharma Science Pty Ltd

INN (Tarptautinis Pavadinimas):

Lamotrigine

Vaisto forma:

Tablet, dispersible

Sudėtis:

Excipient Ingredients: magnesium stearate; magnesium carbonate hydrate; microcrystalline cellulose; povidone; sucralose; polacrilin potassium; Flavour

Vartojimo būdas:

Oral

Vienetai pakuotėje:

30, 56

Recepto tipas:

(S4) Prescription Only Medicine

Terapinės indikacijos:

Lamotrigine is an antiepileptic drug for the treatment of partial and generalised seizures in adults and children.,There is extensive experience with Lamotrigine used initially as ?add-on? therapy. The use of Lamotrigine has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs.,Initial monotherapy treatment in newly diagnosed paediatric patients is not recommended.

Produkto santrauka:

Visual Identification: White to off-white rounded square shaped uncoated tablets debossed with 'H' on multifaceted side and '79' on flat side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Autorizacija statusas:

Licence status A

Leidimo data:

2012-05-03